Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
37.3M
-
Shares change
-
-21.1K
-
Total reported value, excl. options
-
$776M
-
Value change
-
+$4.08M
-
Put/Call ratio
-
0.33
-
Number of buys
-
50
-
Number of sells
-
-79
-
Price
-
$20.82
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2020
162 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2020.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.3M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (5.12M shares), BlackRock Inc. (2.81M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.43M shares), PERCEPTIVE ADVISORS LLC (2.06M shares), Camber Capital Management LP (2M shares), Camber Capital Management LP (2M shares), Rubric Capital Management LP (1.93M shares), VANGUARD GROUP INC (1.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.43M shares), and Rock Springs Capital Management LP (1.18M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.